Cel In the world of surgical medicine there is a major trend towards minimizing the number and size of skin incisions necessary to execute surgeries. This is very appealing from patients’ perspective, reducing or completely eliminating abdominal wall aggression and reducing post-operative pain. Less invasive surgery is also a major component of shorter hospital stays and quicker return to day-to-day activities by the patient. This benefits the patient, the healthcare system and the social-economic environment in general. Single Incision Laparoscopic Surgery (SILS) is seen as the new frontier of this ongoing trend. In a SILS procedure the surgeon operates exclusively through a single incision in the patient’s navel, leaving just one barely-visible scar. However, SILS is very challenging for surgeons, because of the major constraints imposed by both the mode of access and the limited technology currently available. Valuebiotech (VBT) is an SME, spun off from Niguarda Hospital and AIMS Academy (Milano, Italy) and intends to address this problem through highly advanced robotics technology. This technology is designed to take the robot into the abdomen, and provide (intra-abdominal) the various tools necessary to perform a surgical procedure. The MILANO robot can be inserted via a single incision or natural orifice, and then, once inside the cavity, the robot positions itself to perform surgery. Dziedzina nauki medical and health sciencesclinical medicinesurgerysurgical specialtiesmedical and health sciencesclinical medicinesurgerysurgical proceduresengineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringrobotics Program(-y) H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Temat(-y) ICT-37-2014-1 - Open Disruptive Innovation Scheme (implemented through the SME instrument) Zaproszenie do składania wniosków H2020-SMEInst-2014-2015 Zobacz inne projekty w ramach tego zaproszenia Szczegółowe działanie H2020-SMEINST-1-2014 System finansowania SME-1 - SME instrument phase 1 Koordynator VALUEBIOTECH SRL Wkład UE netto € 50 000,00 Adres VIA CUSANI 4 20121 MILANO Włochy Zobacz na mapie MŚP Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant. Tak Region Nord-Ovest Lombardia Milano Rodzaj działalności Private for-profit entities (excluding Higher or Secondary Education Establishments) Linki Kontakt z organizacją Opens in new window Uczestnictwo w unijnych programach w zakresie badań i innowacji Opens in new window sieć współpracy HORIZON Opens in new window Koszt całkowity € 71 429,00
